1. Webster L, Costafreda Gonzalez S, Stringer A, et al. Measuring the prevalence of sleep disturbances in people with dementia living in care homes: a systematic review and meta-analysis. Sleep, 2019. doi:10.1093/sleep/zsz251
2. McCleery J, Sharpley AL. Pharmacotherapies for sleep disturbances in dementia. Cochrane Database Syst Rev. 2020 Nov 15;11(11):CD009178. doi: 10.1002/14651858.CD009178.pub4. PMID: 33189083; PMCID: PMC8094738.
3. Petrovsky DV, McPhillips MV, Li J, Brody A, Caffeé L, Hodgson NA. Sleep disruption and quality of life in persons with dementia: A state-of-the-art review. Geriatr Nurs. 2018 Nov;39(6):640-645. doi: 10.1016/j.gerinurse.2018.04.014. Epub 2018 May 24. PMID: 29803606; PMCID: PMC6252149.
4. Kinnunen KM, Vikhanova A, Livingston G. The management of sleep disorders in dementia: an update. Curr Opin Psychiatry. 2017 Nov;30(6):491-497. doi: 10.1097/YCO.0000000000000370. PMID: 28858007.
5. McCleery J, Cohen DA, Sharpley AL. Pharmacotherapies for sleep disturbances in dementia. Cochrane Database Syst Rev. 2016 Nov 16;11(11):CD009178. doi: 10.1002/14651858.CD009178.pub3. Update in: Cochrane Database Syst Rev. 2020 Nov 15;11:CD009178. PMID: 27851868; PMCID: PMC6464889.
6. Altınyazar V, Kiylioglu N. Insomnia and dementia: is agomelatine treatment helpful? Case report and review of the literature. Ther Adv Psychopharmacol. 2016 Aug;6(4):263-8. doi: 10.1177/2045125316646064. Epub 2016 May 16. PMID: 27536345; PMCID: PMC4971602.
7. Bjerre LM, Farrell B, Hogel M, Graham L, Lemay G, McCarthy L, Raman-Wilms L, Rojas-Fernandez C, Sinha S, Thompson W, Welch V, Wiens A. Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia: Evidence-based clinical practice guideline. Can Fam Physician. 2018 Jan;64(1):17-27. PMID: 29358245; PMCID: PMC5962971.
8. Tampi RR, Tampi DJ, Balachandran S. Antipsychotics, Antidepressants, Anticonvulsants, Melatonin, and Benzodiazepines for Behavioral and Psychological Symptoms of Dementia: a Systematic Review of Meta-analyses. Curr Treat Options Psychiatry. 2017 Mar 1;4(1):55–79.
9. Wang Y-Y, Zheng W, Ng CH, Ungvari GS, Wei W, Xiang Y-T. Meta-analysis of randomized, double-blind, placebo-controlled trials of melatonin in Alzheimer’s disease. Int J Geriatr Psychiatry. 2017;32(1):50–7.
10. Scoralick FM, Louzada LL, Quintas JL, Naves JOS, Camargos EF, Nóbrega OT. Mirtazapine does not improve sleep disorders in Alzheimer’s disease: results from a double-blind, placebo-controlled pilot study. Psychogeriatrics. 2017;17(2):89–96.
11. Kazui H, Adachi H, Kanemoto H, Yoshiyama K, Wada T, Tokumasu Nomura K, et al. Effects of donepezil on sleep disturbances in patients with dementia with Lewy bodies: An open-label study with actigraphy. Psychiatry Res. 2017 May 1;251:312–8.